Skip to content

industry news

Why Some Dental Implant Infections Resist Antibiotics: New Research Points to Titanium Particles

A Rutgers University study published in PNAS Nexus has identified a previously unknown mechanism by which dental implants can fuel their own infections — offering a potential new treatment target.

Dental implants have long been considered a reliable way to replace missing teeth, but a condition called peri-implantitis — a serious infection of the bone and tissue around an implant — affects an estimated one in five implant recipients. Antibiotics frequently fail to control it, and until now, researchers were not sure why.

A study published in the journal PNAS Nexus by scientists at the Rutgers School of Dental Medicine offers a clearer answer. The research found that bacteria living on implant surfaces can produce acidic biofilms that gradually corrode the titanium, releasing billions of microscopic particles into surrounding tissue. Those particles then interfere with the immune cells — called macrophages — that would normally fight infection, locking them into a state of runaway inflammation that progressively damages the jawbone instead of clearing the bacteria.

The research team worked with human tissue samples, cultured immune cells in the laboratory, and a mouse model. They pinpointed a specific calcium channel, called TRPC1, in macrophages as the mechanism the titanium particles exploit. When that channel was blocked in mice, the disease progression was halted — making it the first identified drug target for this condition. The researchers also noted that gentler, non-abrasive cleaning methods around implants may help slow the corrosion process in the first place.

For patients who have implants or are considering them, the findings underscore the importance of consistent professional maintenance and good at-home hygiene around implant sites. Clinicians may also have reason to consider a patient's broader immune and inflammatory profile when managing implant health. Researchers say further work is needed before new drug-based treatments could become available.

Source: ScienceDaily (reporting on Rutgers University / PNAS Nexus)

Published 10/28/2026

← Back to Latest